T1	Outcomes 154 188	feasibility and diagnostic utility
T2	Outcomes 726 742	CYP21 mutations;
T3	Outcomes 839 856	heterozygote rate
T4	Outcomes 1010 1037	wide range of 17-OHP levels
T5	Outcomes 1135 1141	17-OHP
T6	Outcomes 1173 1203	Genetic linkage disequilibrium
T7	Outcomes 1226 1268	CYP21 mutations and chromosome 6p markers.
T8	Outcomes 1309 1351	genotype CYP21 and other relevant markers,
T9	Outcomes 1378 1405	specificity and sensitivity
T10	Outcomes 1409 1501	congenital adrenal hyperplasia screening. CYP21 heterozygote frequency for classic mutations